Process Industries · Chemicals: Specialty · NSE: TATVA · data 2026-10-09
Tatva Chintan Pharma Chem Limited
Health check: Average (4.9/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹1,804.8
Market cap
₹4,340 cr
P/E
82.2
P/B
—
ROE
5.5%
ROCE
7.9%
Debt / equity
0.15
Dividend yield
0.11%
1-year return
70.2%
52-week high
₹2,008.7
52-week low
₹1,044.1
Operating margin
12.5%
Growth
| Revenue (last 12 months) | ₹556 cr |
| Net profit (last 12 months) | ₹51 cr |
| Sales growth, 3 years (yearly) | 6.0% |
| Profit growth, 3 years (yearly) | -2.6% |
Chart patterns
- Ascending triangle — forming (key level ₹1,838.1)
Similar companies
Laxmi Organic Industries Ltd. (LXCHEM) · Ellenbarrie Industrial Gases Limited (ELLEN) · Vishnu Chemicals Limited (VISHNU) · Gujarat Alkalies & Chemicals Ltd. (GUJALKALI) · Dhanuka Agritech Limited (DHANUKA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open TATVA in NSE Scanner →